Tomaralimab

• Target:

  Interleukin|||TLR|||Microtubule Associated|||NOD-like Receptor (NLR) |||MyD88

• Related Pathways:

  Immunology/Inflammation|||Cytoskeletal Signaling

• Purity:

  1

• Bioactivity:

  Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2, used to study myelodysplastic syndromes (MDS) .

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1449294-76-1